A study from Abbott found that employing its cardiac valve repair implant during earlier phases of heart failure—when a patient’s leaky mitral valve is still considered to be functional—could lead to ...

Abbott Laboratories ABT recently announced FDA approval for its latest version of MitraClip heart valve repair device to treat mitral regurgitation (MR). With the approval for the fourth-generation ...

Abbott Laboratories ABT recently received the CE Mark for its fourth-generation MitraClip Transcatheter Mitral Valve Repair (TMVR) System, MitraClip G4. It is a renowned minimally invasive mitral ...

FAVORABLE LATE-BREAKING CLINICAL TRIAL DATA FROM INITIAL COMMERCIAL USE PRESENTED ON TRANSCATHETER MITRAL VALVE REPAIR SYSTEM AT ACC 2015 Vaughn's story shows how MitraClip can help people with a ...

Results Show Treatment Provides Clinical Benefits and Improves Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk ABBOTT PARK, Ill. -- Abbott ...

SAN DIEGO, Sept. 23, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip ® device to ...

Versions of the device have been available in the EU since 2008. The G4 had already been approved for use in the U.S. by the Food and Drug Administration. It treats mitral regurgitation, a condition ...

Abbott Laboratories has received an expanded indication for MitraClip. The Abbott Park, IL-based company’s new indication addresses the secondary form of mitral regurgitation and significantly ...

Treatment with Minimally Invasive Device Can Improve Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk Abbott Park, Ill. — Abbott today announced ...

ABBOTT PARK, Ill., Jan. 13, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved a first-of-its-kind clinical trial that will compare ...

Secondary mitral regurgitation (MR) can be a serious complication of heart failure — in a recent study, two-thirds of the people who were taking the maximum recommended doses of drugs for severe forms ...